Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gregory S. Wessels currently holds 16,000 shares of Aprea Therapeutics, Inc. (APRE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory S. Wessels has been a net neutral trader of APRE stock. They have purchased $0 and sold $0 worth of shares.
Gregory S. Wessels's most recent insider trade was on Feb 25, 2021, when they sold 16,000 shares at $0.00 per share.
Gregory S. Wessels serves as Executive at Aprea Therapeutics, Inc. (APRE). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Gregory S. Wessels holds the position of Executive at Aprea Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Gregory S. Wessels has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Gregory S. Wessels was on Feb 25, 2021, when they purchased $0 worth of APRE shares. This transaction involved 16,000 shares at N/A per share.
Gregory S. Wessels currently owns 16,000 shares of Aprea Therapeutics, Inc. (APRE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gregory S. Wessels's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gregory S. Wessels has 1 Form 4 filings on record as an insider at Aprea Therapeutics, Inc..
Set alerts for Gregory S. Wessels and 40,000+ other insiders.